Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Axon Partners GroupXMAD:APG 84 Days Sales Outstanding is 70.26 as of Dec. 2025, which is 23% below its 10-year median of 90.83. GuruFocus rates XMAD:APG with a GF Score™ of 84/100 and a GF Value™ of €25.84 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,061 Business Services companies, Axon Partners Group ranks worse than 71.44% on this metric.
The historical rank and industry rank for Axon Partners Group's Days Sales Outstanding or its related term are showing as below:
XMAD:APG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 72.35 Med: 90.83 Max: 101.4
Current: 78.8
During the past 6 years, Axon Partners Group's highest Days Sales Outstanding was 101.40. The lowest was 72.35. And the median was 90.83.
XMAD:APG's Days Sales Outstanding is ranked worse than 71.44% of 1061
companies
in the Business Services industry
Industry Median: 56.77
vs XMAD:APG: 78.80
Axon Partners Group's Days Sales Outstanding
increased
from Dec. 2024 (39.32) to Dec. 2025 (70.26).
Axon Partners Group (XMAD:APG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Axon Partners Group Days Sales Outstanding Related Terms
Axon Partners Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Axon Partners Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:APG vs VRSK, EFX, BAH: Days Sales Outstanding Comparison
For the Consulting Services subindustry, Axon Partners Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Axon Partners Group Days Sales Outstanding vs Business Services Industry
For the Business Services industry and Industrials sector, Axon Partners Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Axon Partners Group's Days Sales Outstanding falls into.
Axon Partners Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axon Partners Group (XMAD:APG) has a Days Sales Outstanding of 70.26 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Axon Partners Group and its competitors. This is 23% below median its historical median of 90.83. Over the past decade, Axon Partners Group's Days Sales Outstanding has ranged from 72.35 to 101.40. According to the industry distribution chart, Axon Partners Group ranks #758 out of 1061 companies in the Business Services industry, placing it in the top 71.4%.
Is Axon Partners Group's Days Sales Outstanding too high?
Axon Partners Group's current Days Sales Outstanding of 70.26 is 23% below median its 10-year median of 90.83. Over the past 10 years, this metric has ranged from a low of 72.35 to a high of 101.40. The Business Services industry median Days Sales Outstanding is 56.77. Axon Partners Group's value of 70.26 is 23.8% above this industry median. Based on the distribution chart, Axon Partners Group ranks #758 out of 1061 companies in the Business Services industry, which is below the industry midpoint. Overall, Axon Partners Group has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Axon Partners Group's Days Sales Outstanding compare to VRSK and EFX?
According to the Business Services industry distribution chart, Axon Partners Group ranks #758 out of 1061 companies for Days Sales Outstanding. This places Axon Partners Group in the lower half of its industry. The industry median Days Sales Outstanding is 56.77. Axon Partners Group's value of 70.26 is 23.8% above this benchmark. Historically, Axon Partners Group's own Days Sales Outstanding has ranged from 72.35 to 101.40 over the past decade. While the company's 10-year median is 90.83 vs. the industry median of 56.77, Axon Partners Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Business Services company?
The median Days Sales Outstanding among Business Services companies is 56.77, based on 1,061 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Axon Partners Group's current Days Sales Outstanding of 70.26 is 23.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Axon Partners Group and its competitors. For the Business Services industry, the median Days Sales Outstanding is 56.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Axon Partners Group's current Days Sales Outstanding is 70.26, which is 23% below median its own 10-year median of 90.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axon Partners Group stock overvalued right now?
Based on GuruFocus' analysis, Axon Partners Group (XMAD:APG) is currently considered Possible Value Trap. The stock's GF Value™ is €25.84, compared to a current price of €17.60 — trading 31.9% below its estimated fair value. The current Days Sales Outstanding is 70.26, which is 23% below median its 10-year median of 90.83 and 23.8% above the Business Services industry median of 56.77. Axon Partners Group's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Axon Partners Group (XMAD:APG), the current Days Sales Outstanding is 70.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Axon Partners Group (XMAD:APG) Overvalued in 2026?
Based on GuruFocus' analysis, Axon Partners Group stock appears to be undervalued.
The current stock price of €17.60 is trading 31.9% below its estimated GF Value™ of €25.84.
GuruFocus considers Axon Partners Group to be Possible Value Trap.
Key valuation signals for XMAD:APG:
Days Sales Outstanding: 70.26 (23% below median its 10-year median of 90.83)
GF Value™: €25.84 vs. price of €17.60 (31.9% below fair value)
Industry Position: 23.8% above the Business Services median (#758 of 1061)
No single metric tells the full story. See the XMAD:APG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Axon Partners Group SA is an investment and consulting firm. It offers advisory services in the area of Cybersecurity, Digital Platforms, Cloud, Fog & Edge Computing, AI & Big Data, Cleantech, and Sustainability, among others. It also investment strategies consisting Direct Investment, Fund of Funds, Corporate Venture Capital, and Special Opportunities.
84GF Score
Get the complete analysis for XMAD:APG
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:APG has been successfully added to your 
